病理学家在多学科癌症会议上对患者护理的影响：文献证据
The Impact of the Pathologist in Multidisciplinary Cancer Conferences on Patient Care : Evidence From the Literature
影响因子:1.90000
分区:医学4区 / 病理学3区
发表日期:2023 Apr 04
作者:
Anna Plotkin, Ekaterina Olkhov-Mitsel, Anna R Gagliardi
摘要
多学科的癌症会议（MCC）是治疗患有复杂健康问题的患者的重要工具，可帮助临床医生在肿瘤学实践中取得最佳结局。为了探讨病理学家在MCC的作用，我们对有关该主题的先前研究进行了综述。我们通过搜索Medline，Embase和Cochrane库进行了范围审查，以用于英语定性，定量，定量或多种/混合方法研究病理学家对MCC的作用和影响。我们使用Microsoft Excel提取了76个研究结果，我们只包括3项研究，涉及病理学家对MCC对癌症病例的审查。所有3项研究都表明，专家病理学评论提高了诊断和精致疾病分期的准确性，从而导致黑色素瘤，乳腺癌和妇科癌的治疗变化。尚无研究探讨参与MCC的病理学家或用于促进或支持病理学家参与的策略或干预措施的障碍。我们确定了关于病理学家在MCC中作用的研究很少。鉴于涉及病理学家对诊断和优化治疗的准确性的MCC的积极影响，因此有必要进一步建立病理学家在MCC中的作用和影响，以及如何促进或支持病理学家的参与。
Abstract
Multidisciplinary cancer conferences (MCCs) are important tools in the treatment of patients with complex health issues, helping clinicians achieve optimal outcomes in oncological practice. To explore the role of pathologists at MCCs, we conducted a review of prior research on this topic.We conducted a scoping review by searching MEDLINE, EMBASE, and the Cochrane Library for English-language qualitative, quantitative, or multiple/mixed methods studies on the role and impact of pathologists on MCCs. We used Microsoft Excel to extract data.Of 76 research results, we included only 3 studies that involved review of cancer cases by pathologists for MCCs. All 3 studies showed that expert pathology review improved the accuracy of diagnosis and refined disease staging, leading to changes in the management of melanoma, breast cancer, and gynecologic cancer. No studies explored the barriers to pathologists participating in MCCs or the strategies or interventions employed to promote or support pathologist involvement.We identified a paucity of studies on the role of pathologists in MCCs. Given the positive impact of MCCs involving pathologists on the accuracy of diagnosis and optimization of treatment, future research is warranted to further establish the role and impact of pathologists in MCCs and how to promote or support pathologists' involvement.